Fifth Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension: A Case Based Conference


Pulmonary Hypertension: The Hidden Killer

J. Thomas Heywood, MD, FACC, identifies how to diagnose pulmonary hypertension, and reviews different types and how they are diagnosed.
J. Thomas Heywood, MD, FACC

J. Thomas Heywood, MD, FACC

Director, Advanced Heart Failure and Mechanical Circulatory Support Program
Scripps Clinic
La Jolla, California

Pulmonary Arterial Hypertension: It’s the Lungs

Rajeev C. Mohan, MD, explains the pathophysiology of Pulmonary Arterial Hypertension versus Pulmonary Venous Hypertension, and reviews diagnosis and treatment options.
Rajeev Mohan, MD

Rajeev Mohan, MD

Advanced Heart Failure and Mechanical Circulatory Support Program
Scripps Clinic
La Jolla, California

Pulmonary Venous Hypertension: Common and Overlooked

Ajay V. Srivastava, MD, FACC, identifies Pulmonary Venous Hypertension as the most common form of the disease and recalls how it is a hidden killer, often diagnosed late.

Rheumatic Disease and Pulmonary Disease: Pearls and Tips

Richard M. Keating, MD, FACR, FACP, explains how to recognize and diagnose a Systemic Autoimmune Rheumatic Disease (SARD) in patients presenting with Pulmonary Hypertension.
Richard Keating, MD, FACR, FACP

Richard Keating, MD, FACR, FACP

Associate Program Director
Rheumatology Fellowship
Scripps Clinic
La Jolla, California

Blood Clots and Pulmonary Hypertension: When to Call the Surgeon

Demosthenes Papamatheakis, MD, reviews a case of Pulmonary Hypertension with blood clots, and explains how they identified the problem and provided treatment.
Demosthenes Papamatheakis, MD

Demosthenes Papamatheakis, MD

Pulmonologist
Assistant Professor of Medicine
University of California, San Diego
La Jolla, California

Pulmonary Arterial Hypertension in Chronic Lung Disease: Diagnosis and Management

Kelly Fan, MD, identifies the group three disease of Pulmonary Hyperpertenion (PH), due to chronic lung disease and hypoxia. Dr. Fan discusses the prognosis and why it is a problem in patients with chronic lung disease, describes diagnostic ...
Kelly Fan, MD

Kelly Fan, MD

Pulmonary and Critical Care Attending
Scripps Clinic
La Jolla, California

Adult Congenital Heart Disease: More Common Than You Think!

Dr. Laith Alshawabkeh defines pulmonary hypertension as it relates to adult congenital heart disease and discusses prevalence and clinical approaches to patients using case examples.
Laith Alshawabkeh, MD, FACC

Laith Alshawabkeh, MD, FACC

Assistant Clinical Professor of Medicine
Director, Adult Congenital Heart Disease Program
UC San Diego Sulpizio Cardiovascular Center
La Jolla, California

Pulmonary Hypertension: Putting it All Together

J. Thomas Heywood, MD, FACC, reviews five important things to remember about Pulmonary Hypertension.
J. Thomas Heywood, MD, FACC

J. Thomas Heywood, MD, FACC

Director, Advanced Heart Failure and Mechanical Circulatory Support Program
Scripps Clinic
La Jolla, California

Return to Main Menu »

Course Overview

Pulmonary hypertension (PH) is a common and widely misunderstood syndrome that results from a surprisingly large number of disease processes. It can occur at any age and the risk of developing PH increases with age and other medical conditions. Great strides have been made in the past 15 years in diagnosing and treating pulmonary arterial hypertension (PAH) so that the natural history of PAH is rapidly changing. On the other hand, the more common clinical variant, pulmonary venous hypertension (PVH) has been largely unaffected by medical therapy. In addition, there is often a divide between those whose treat PAH and those clinicians whose patients have PVH and are frustrated by the lack of effective therapy.

This conference will be unique in that it will cover all forms of pulmonary hypertension. Expert faculty will discuss the epidemiology of PH, how PH is diagnosed, and the poor outcomes associated with PH when left untreated. Clinicians will leave with a better understanding of the difference between PAH and PVH and why the difference matters. Therapies for PAH and PVH will also be discussed with reference to current clinical guidelines. Participants will return to their practice equipped with the latest evidence base and practical information to improve patient outcomes.

Educational Objectives

  • Describe the epidemiology and pathophysiology of pulmonary hypertension.
  • Determine who is at risk for pulmonary hypertension and effectively diagnose patients.
  • Recognize the difference between PAH and PVH and how this translates into therapy.
  • Outline the current approach to pulmonary hypertension treatment in the presence of related or underlying diseases.
  • Evaluate current pharmacologic and medical management strategies for patients with pulmonary hypertension.
  • Incorporate novel therapies into patient care for improved outcomes.
  • Identify when to refer patients for specialty treatment.

Target Audience

  • Cardiologists
  • Pulmonologists
  • Internists
  • Primary Care Physicians
  • Nurses, Nurse Practitioners, Physician Assistants

View Faculty Disclosures »